| Name: | Regorafenib |
| CAS NO.: | 755037-03-7 |
| Purity: | ≥99% |
| Function: | anticancer |
| Quality standard: | BP/EP/USP/Enterprise Standard |
| Documents: | DMF, WC, COPP |
 |
Product Description
Regorafenib (BAY 73-4506, Stivarga,755037-03-7) is a new oral small molecule multi-kinases inhibitor. It can inhibit the target kinases associated with angiogenesis and tumorigenesis. The pathway influenced by regorafenib and the biomarkers for monitoring the efficacy of regorafenib become hot spots. Because of its wide spectrum kinase inhibitory activity, the utilization of regorafenib in many clinical indications are also carried out extensively. Since regorafenib is approved with the box warning, its side effects can not be ignored.
Hits: 【Print】
Pre:Gemcitabine Next:Olaparib